M
Mascoma
Biofuel company that produces cellulosic ethanol made from wood and switchgrass
About Mascoma
Mascoma was established in 2005 as a biofuel enterprise focused on producing cellulosic ethanol from non-food materials like wood and switchgrass. The company originated from research at Dartmouth College and was co-founded by professors Lee Lynd and Charles Wyman, alongside CEO Robert Johnsen. Lynd, a distinguished professor in environmental engineering, has dedicated his career to the sustainable production of energy from plant biomass, co-founding Mascoma to translate his academic research into commercial applications. The firm's name is a nod to Mascoma Lake, situated near its Lebanon, New Hampshire, headquarters.
Initially, Mascoma attracted significant investment from venture capital firms such as Flagship Ventures and Khosla Ventures in 2006. The company's primary business was centered on developing and commercializing bio-engineered yeasts and other microbes to enhance the efficiency and cost-effectiveness of renewable fuel and chemical production. Its core technology platform, Consolidated Bioprocessing (CBP), aimed to streamline the conversion of cellulosic biomass into ethanol. A key product, Mascoma Grain Technology (MGT), utilized a genetically-modified yeast that produces its own enzymes, thereby improving ethanol yields from corn-based processes.
In a significant strategic shift, Mascoma entered into an exclusive partnership with Lallemand Inc. in 2012 to manufacture and distribute its MGT yeast product. This collaboration culminated in November 2014 when Lallemand acquired Mascoma's yeast business assets, including the company name, trademarks, all proprietary yeast strains, and the entire research and development team. Following the acquisition, the R&D facility in Lebanon, NH, was rebranded as Mascoma LLC and now operates as a research and development center for Lallemand. It functions as a semi-independent group, leveraging synthetic biology and metabolic engineering to create new products for the global fuel, food, and feed markets. The remaining assets of the original Mascoma Corp. were subsequently renamed Enchi Corporation.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Boston, United States
- Employees
- 76
- Open positions
- None listed
- Dealroom signal
- 72.6/100
- Industry
- Health
- Sub-industry
- Clean Energy, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Wood, Spinout, Biofuel, Sustainable Development Goals, Biotech and Pharma, Climate Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Sep 2010
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Nov 2014 | $0 | — | Lallemand | — |
| DEBTDebt | Aug 2011 | $50M | — | Pinnacle Ventures | — |
Growth signals
Latest recorded traffic for Mascoma is 220 monthly website visits, down 56.9% over the last three months. Mascoma's team grew 1.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
QterosBiofuels from Advanced Microbiology |
Marlborough, United States | Closed | 10 | $54M | $28M |
EuglenaMicroalgae-based food, cosmetics, and biofuel development |
Tokyo, Japan | Operational | |||
TransAlgaeDevelops an algae-based platform for oral delivery of high value products for Animal Health and Crop Protection |
Rehovot, Israel | Operational | |||
GaldieriaCreator of microalgae technology aimed at enhancing the recovery efficiency of precious metal recycling |
Tokyo, Japan | Operational | |||
AquaporinDeveloping advanced biotechnologies to purify water and desalinate seawater |
Kongens Lyngby, Denmark | Operational | |||
LygosLygos is providing biotechnology solutions for today's renewable chemical challenges |
Emeryville, United States | Acquired | |||
LigniLabsPioneers bio-based encapsulation using lignin from wood for active ingredient delivery |
Wiesbaden, Germany | Operational | |||
InnovacellAutologous cell therapies for treating incontinence |
Tokyo, Japan | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
NYSERDA
Series A2 investors entered at this stage
Series B and later3 investors entered at this stage
General Catalyst
Kleiner Perkins
Pinnacle Ventures
Other known investors2 additional known investors
Dartmouth College
Lallemand
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mascoma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mascoma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










